ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Glioma
Brain Cancer
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Dallas, TX, USA:

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

Dallas, Texas, United States and 61 other locations

This multi-site, Phase 1/2a clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen o...

Enrolling
Glioblastoma Multiforme
Drug: Perillyl alcohol

Phase 1, Phase 2

NeOnc Technologies

Dallas, Texas, United States and 7 other locations

are also impermeable to the passage of therapeutic molecules from the blood to the brain. The development of effective treatments against glioblastoma...

Enrolling
Glioblastoma
Recurrent Glioblastoma
Device: SonoCloud-9 (SC9)
Drug: Temozolomide

Phase 3

Carthera

Dallas, Texas, United States and 30 other locations

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting
Glioblastoma Multiforme
Device: Optune®
NovoCure
NovoCure

Dallas, Texas, United States and 132 other locations

receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma (GBM) expr...

Enrolling
Advanced Non-Small Cell Squamous Lung Cancer
Epidermal Growth Factor Receptor C797S
Drug: BDTX-1535 monotherapy

Phase 1, Phase 2

Black Diamond Therapeutics

Dallas, Texas, United States and 32 other locations

This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given...

Enrolling
Glioma
Drug: Rhenium Liposome Treatment

Phase 1, Phase 2

Plus Therapeutics

Dallas, Texas, United States and 2 other locations

The purpose of this study is to examine the effects of Tofacitinib in patients with recurrent Glioblastoma....

Enrolling
Glioblastoma
Drug: Tofacitinib 10mg

Phase 3

The University of Texas System (UT)
The University of Texas System (UT)

Dallas, Texas, United States

This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...

Active, not recruiting
Glioblastoma Multiforme, Adult
Drug: Berubicin
Drug: Lomustine

Phase 2

CNS Pharmaceuticals
CNS Pharmaceuticals

Dallas, Texas, United States and 47 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems